613 related articles for article (PubMed ID: 18310816)
61. [Effects of raloxifene on bone biomarkers in postmenopausal women on maintenance haemodialysis].
Matsuo K; Fujinaga M; Tsuchiya K; Nakamoto M; Yasunaga C
Clin Calcium; 2005 Sep; 15 Suppl 1():92-6; discussion 96-7. PubMed ID: 16272639
[TBL] [Abstract][Full Text] [Related]
62. A once-yearly IV bisphosphonate for osteoporosis.
Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
[No Abstract] [Full Text] [Related]
63. Bone quality--the material and structural basis of bone strength and fragility.
Seeman E; Delmas PD
N Engl J Med; 2006 May; 354(21):2250-61. PubMed ID: 16723616
[No Abstract] [Full Text] [Related]
64. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
65. Drugs for prevention and treatment of postmenopausal osteoporosis.
Treat Guidel Med Lett; 2002 Nov; 1(3):13-8. PubMed ID: 15529101
[No Abstract] [Full Text] [Related]
66. [Effects of estrogen on bone-turnover and its prevention and control of osteoporosis ].
Lin SQ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):728-9. PubMed ID: 15949374
[No Abstract] [Full Text] [Related]
67. Annual zoledronic acid for osteoporosis.
BMJ Group
Drug Ther Bull; 2008 Dec; 46(12):93-6. PubMed ID: 19056701
[TBL] [Abstract][Full Text] [Related]
68. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
Woodis CB
Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
[TBL] [Abstract][Full Text] [Related]
69. The therapeutic use of bisphosphonates.
Compston JE
BMJ; 1994 Sep; 309(6956):711-5. PubMed ID: 7950525
[No Abstract] [Full Text] [Related]
70. Efficacy and safety of currently marketed anti-osteoporosis medications.
Reginster JY; Neuprez A; Dardenne N; Beaudart C; Emonts P; Bruyere O
Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):809-34. PubMed ID: 25432354
[TBL] [Abstract][Full Text] [Related]
71. [Long term effects of raloxifen on the bones].
Eiken PA
Ugeskr Laeger; 2008 Jan; 170(4):224-6. PubMed ID: 18282451
[TBL] [Abstract][Full Text] [Related]
72. [Impacts on bone mineral density].
Kurth A
Orthopade; 2014 Feb; 43(2):182. PubMed ID: 24693554
[No Abstract] [Full Text] [Related]
73. Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia.
Dane C; Dane B; Cetin A; Erginbas M
Gynecol Endocrinol; 2008 Apr; 24(4):207-13. PubMed ID: 18382907
[TBL] [Abstract][Full Text] [Related]
74. The effect of raloxifene in association with vitamin D on vaginal maturation index and urogenital symptoms in postmenopausal osteoporotic women.
Zeyneloglu HB; Oktem M; Haberal NA; Esinler I; Kuscu E
Fertil Steril; 2007 Aug; 88(2):530-2. PubMed ID: 17336964
[TBL] [Abstract][Full Text] [Related]
75. Causes of age-related bone loss and bone fragility: an alternative view.
Raisz LG; Seeman E
J Bone Miner Res; 2001 Nov; 16(11):1948-52. PubMed ID: 11697790
[No Abstract] [Full Text] [Related]
76. The role of markers of bone turnover in the assessment of fracture risk in postmenopausal women.
Delmas PD
Osteoporos Int; 1998; 8 Suppl 1():S32-6. PubMed ID: 9682795
[No Abstract] [Full Text] [Related]
77. [Assessment of bone quality. Effects of bisphosphonates, raloxifene, alfacalcidol, and menatetrenone on bone quality: collagen cross-links, mineralization, and microdamage].
Saito M
Clin Calcium; 2008 Mar; 18(3):364-72. PubMed ID: 18310825
[TBL] [Abstract][Full Text] [Related]
78. [Effects of SERMs on bone health. SERM and metabolic markers of bone].
Takami M; Shimada H
Clin Calcium; 2010 Mar; 20(3):365-71. PubMed ID: 20190366
[TBL] [Abstract][Full Text] [Related]
79. [CORE study].
Mizunuma H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():294-8. PubMed ID: 18161121
[No Abstract] [Full Text] [Related]
80. [Antiresorptive therapy for osteoporosis and bone quality].
Kishimoto H
Clin Calcium; 2005 Jun; 15(6):1007-11. PubMed ID: 15930715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
